For research & educational purposes only. This article is a neutral, procedural reference for laboratory / in-vitro research handling — not medical advice or a usage recommendation. These materials are not for human or animal consumption.
On this page
What BPC-157 is
BPC-157 is a small chain of 15 amino acids copied from a protective protein found in human stomach juice. It is supplied as an analytical-grade reference material for laboratory research.
Where it comes from
BPC-157 is short for 'Body Protection Compound 157.' It was identified in the 1990s from a larger protein found in human gastric juice — the fluid the stomach uses to defend and repair its own lining. Researchers isolated a stable 15-amino-acid stretch of that protein and found it held together well outside the body, which is a big part of why it became such a widely studied tool in tissue-repair research.
What it does — in plain terms
Think of BPC-157 as a 'come here and rebuild' message for cells. In animal studies, when tissue is damaged, it appears to help the body patch things up faster — sending repair cells and fresh blood supply to the injured area. Because the original protein comes from the stomach, a lot of the research looks at the gut, plus connective tissue like tendons and ligaments and muscle. It's most often studied around repair and recovery.
How it works
The simplest way to picture BPC-157 is as a repair dispatcher. Across animal and cell studies it does not appear to force a brand-new process so much as speed up the healing the body already knows how to do — getting repair cells and, above all, fresh blood supply to a damaged area faster.
The most consistent thread in the literature is angiogenesis: the growth of new blood vessels. Injured tissue can only rebuild if it receives oxygen and nutrients, and study after study describes BPC-157 promoting new vessel formation, in large part by interacting with the VEGF pathway — a master switch for blood-vessel growth. More supply lines into a damaged tendon, muscle, or gut wall means faster, more complete repair in these models.
A second recurring theme is the nitric-oxide (NO) system, which governs blood flow and vessel tone; several papers describe BPC-157 modulating this pathway. Researchers have also reported effects on growth-factor signaling and, in nerve-injury models, on the gut-brain axis — consistent with the idea that a molecule derived from a gut-protective protein has broad tissue-maintenance roles rather than one narrow target.
What the research shows
BPC-157 is unusual among research peptides in how much of its literature centers on structural repair — tendon, ligament, muscle, and the gut lining — rather than a single receptor. It is also important to stay clear-eyed: almost all of this evidence is preclinical (animal and cell models), and reviewers repeatedly note that rigorous human trials are still lacking. With that context, here is what some of the key published work actually reports.
- Cell & Tissue Research, 2019 — reviewed BPC-157's effects on musculoskeletal soft-tissue healing, describing accelerated recovery of tendon, ligament, and muscle in animal models.
- Journal of Applied Physiology, 2011 — found that BPC-157 improved the healing and function of injured tendon cells in the lab, including better cell survival and migration into the wound.
- Frontiers in Pharmacology, 2021 — summarized the wound-healing literature, highlighting BPC-157's consistent pro-healing and angiogenic (new-blood-vessel) effects across different tissue types.
- Current Pharmaceutical Design, 2020 — examined BPC-157 in models of NSAID-induced gut damage, where it helped protect the stomach and intestinal lining.
- HSS Journal, 2025 — a systematic review in orthopaedic sports-medicine research took stock of the evidence base — and stressed that most of it remains preclinical.
What BPC-157 is studied for
Tendon and ligament repair. This is the most-studied use. In animal models BPC-157 speeds the healing of injured tendons and ligaments — tissues that are notoriously slow to mend because they have such a poor blood supply of their own.
Muscle and soft-tissue recovery. Researchers study how it affects recovery from muscle crush and strain injuries, again largely through improved blood supply and faster migration of repair cells into the damaged area.
The gut lining. Because BPC-157 comes from a stomach-protective protein, a large slice of the research looks at the GI tract — protecting the stomach and intestinal lining against injury, including damage caused by NSAIDs.
New blood-vessel growth (angiogenesis). The mechanism that ties the rest together. Much of the repair effect is attributed to BPC-157 encouraging new blood vessels to form through the VEGF pathway, restoring the supply lines that tissue needs to rebuild.
Storage & handling
As a lyophilized (freeze-dried) powder, BPC-157 reference material is most stable kept cold and dark — refrigerated, or frozen for longer holds. Once reconstituted with bacteriostatic water it should be refrigerated at roughly 2-8 °C, kept out of light, and protected from repeated freeze-thaw cycles. See the reconstitution reference below for the concentration math.
Plain-language explanations describe what researchers study — not what any product does for a person, and not medical advice. Every material here is sold for laboratory research use only and is not for human or animal use.
Reconstitution reference
Standard laboratory reconstitution volumes for BPC-157, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.
| Product | Vial | Bacteriostatic water | Resulting concentration |
|---|---|---|---|
| BPC-157 | 10 mg | 2 mL | 5 mg/mL |
| GLOW (GHK-Cu + BPC-157 + TB-500) | 70 mg | 3 mL | ~23.3 mg/mL |
| KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) | 80 mg | 3 mL | ~26.7 mg/mL |
Frequently asked questions
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide based on a sequence found in a protective protein in human gastric juice. It is supplied here as an analytical-grade reference material for laboratory research use only.
How does BPC-157 work in research?
Across animal and cell studies, BPC-157 appears to accelerate the body's normal repair response — most consistently by promoting angiogenesis (new blood-vessel growth) through the VEGF pathway, and by modulating the nitric-oxide system that governs blood flow. Better blood supply to injured tissue is associated with faster, more complete healing in these models.
What has BPC-157 been studied for?
The largest bodies of research cover tendon and ligament healing, muscle and soft-tissue recovery, and protection of the stomach and intestinal lining. Nearly all of this evidence comes from animal and cell models rather than human clinical trials.
Is BPC-157 supported by human clinical trials?
Not substantially. The published evidence is overwhelmingly preclinical. Recent reviews — including a 2025 systematic review in orthopaedic sports medicine — emphasize that well-controlled human trials are still lacking, which is an important caveat when interpreting the research.
How is BPC-157 stored and reconstituted?
Keep the lyophilized powder cold and dark; reconstitute with bacteriostatic water and refrigerate the solution at about 2-8 °C, avoiding repeated freeze-thaw cycles. See the VNG reconstitution guide for the concentration math.
Published research
A selection of peer-reviewed and clinical literature indexed on PubMed. Provided so qualified researchers can locate the primary sources — inclusion here is not a claim about any product or outcome.
- Peer-reviewed studyPharmaceuticals (Basel, Switzerland) · 2025
BPC-157 peptide: medical applications — literature & patent review
View on PubMed - Peer-reviewed studyCell and tissue research · 2019
BPC-157 and musculoskeletal soft-tissue healing
View on PubMed - Systematic reviewHSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025
BPC-157 in orthopaedic sports medicine — systematic review
View on PubMed - Peer-reviewed studyFrontiers in pharmacology · 2021
BPC-157 and wound healing
View on PubMed - Peer-reviewed studyAlternative therapies in health and medicine · 2021
BPC-157 and knee pain — clinical study
View on PubMed - Peer-reviewed studyCurrent pharmaceutical design · 2018
BPC-157, growth factors & tissue healing
View on PubMed - Peer-reviewed studyNeural regeneration research · 2022
BPC-157 and the central nervous system
View on PubMed - Peer-reviewed studyCurrent pharmaceutical design · 2020
BPC-157 and NSAID-induced gut damage
View on PubMed - Peer-reviewed reviewCurrent reviews in musculoskeletal medicine · 2025
BPC-157 for musculoskeletal healing — narrative review
View on PubMed - Lab / formulation studyJournal of applied physiology (Bethesda, Md. : 1985) · 2011
BPC-157 and tendon-cell healing — lab study
View on PubMed
References & resources
Continue reading
- BPC-157 vs TB-500: Two Repair Peptides, Two Different MechanismsBoth appear in tissue-repair research, but one is a gastric-derived pentadecapeptide and the other a thymosin beta-4 fragment. Mechanism, evidence and handling compared.
- KPV vs BPC-157: Inflammatory Signalling vs Tissue RepairBoth appear in gastrointestinal research, which is why they get compared. The pathways each is studied for are different.
Related reference materials
VNG Research Team
VNG Labs supplies analytical-grade reference materials with lot-matched Certificates of Analysis. Our write-ups are neutral, source-cited references for qualified and independent researchers.
More from LearnResearch use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.

